Powered by: Motilal Oswal
2024-05-31 12:46:05 pm | Source: Accord Fintech
Eiko LifeSciences trades higher on incorporating limited liability partnership

Eiko LifeSciences is currently trading at Rs. 50.95, up by 0.85 points or 1.70% from its previous closing of Rs. 50.10 on the BSE.

The scrip opened at Rs. 51.30 and has touched a high and low of Rs. 51.30 and Rs. 50.01 respectively. So far 802 shares were traded on the counter.

The BSE group 'X' stock of face value Rs. 10 has touched a 52 week high of Rs. 81.32 on 25-Jan-2024 and a 52 week low of Rs. 46.81 on 26-Jun-2023.

Last one week high and low of the scrip stood at Rs. 51.81 and Rs. 49.10 respectively. The current market cap of the company is Rs. 69.32 crore.

The promoters holding in the company stood at 24.23%, while Non-Institutions held 75.77% stake in the company.  

Eiko Lifesciences has incorporated a Limited Liability Partnership namely ‘Eiko Scientific Solutions LLP’ on May 30, 2024. The venture focuses on clinical research, development, and innovation in specialty chemicals, healthcare, and other medical fields, including the import and export of innovative technologies. The Board has approved an investment of up to Rs 5 crore over the next three years to support this initiative.

Eiko LifeSciences is a leading manufacturer, supplier and exporter of Speciality Chemicals and Pharma Intermediates in India and Globally.

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here